Searched for
SUN PHARMA Q3 RESULTS HIGHLIGHTS
Central Drugs Laboratories find 46 drug samples not of standard quality for MayHealth officials revealed that in May 2026, 46 drug samples tested by Central Drugs Laboratories and 113 by State Drugs Testing Laboratorie...- Reliance, financials and defence top investment picks as market leadership broadens: Rahul ShahReliance Industries is poised for a turnaround, with strong earnings, a Jio Platforms IPO, and AI/energy investments promising significant ...
- Best proverb of the day: “A man may rise like the sun through ambition, but true strength shines like the moon through balance, strength, and calm” — a lesson in ambition, inner power, and emotional masteryBest Proverb of the Day: A timeless Greek proverb highlights that ambition fuels outward growth like the sun, while inner calm and strength...
- Cipla shares jump 4% as Citi puts stock on 90-day catalyst watch. What's driving the optimism?Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...
- Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGCIndian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...
- Summer Solstice 2026 June 21: Why it’s the longest day of the year, its significance, science behind it, and how it affects youSummer Solstice 2026: Today, 21 June 2026, marks the Summer Solstice, the longest day of the year in the Northern Hemisphere. Caused by Ear...
- Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...
- June 21 Cosmic Forecast: How Sun in Cancer and Mars in Taurus Will Impact Every Zodiac SignJune 21, 2026 brings one of the most significant astrological shifts of the month as the Sun enters Cancer and Mars moves into Taurus on th...
- Weekly Horoscope for ♋ CANCER (June 20 - June 26, 2026): A Powerful New Chapter Begins as Confidence and Clarity ReturnCancer Weekly Horoscope (20th June 2026 to 26th June 2026): Cancer, this week marks the beginning of a powerful personal cycle as the Sun e...
- When Is Summer Solstice 2026? Date, Time, Spiritual Meaning and Zodiac Signs Most AffectedThe Summer Solstice will occur on June 21, 2026, marking the official start of summer in the Northern Hemisphere and bringing the longest d...
- ICICI Prudential AMC shares fall 2% as IPO lock-in expiry frees up Rs 1.2 lakh crore stake for tradeICICI Prudential AMC shares dropped 2% to Rs 513 as 34.4 crore shares became eligible for trade post IPO lock-in expiry. The company's stoc...
- Reality Check: What triggered Accenture's historic stock plungeAccenture's biggest-ever stock plunge was driven by weaker revenue guidance, slowing bookings and rising investor concerns that AI-led disr...
- Buy, Sell or Hold: Morgan Stanley raises target price on NYKAA; Elara Capital maintains buy on Devyani InternationalBrokerage views on Indian equities are mixed as Morgan Stanley raises Nykaa's target price on ambitious FY30 growth plans. Conversely, conc...
- This powerful UFO isn’t alien life, it’s a black hole unleashing a cosmic stormA mysterious object speeding across the universe might look like a UFO, but the real story is even more fascinating. Scientists have discov...
- Accenture net income rises to $2.39 billion during March-May quarterAccenture announced strong financial results for its March-May quarter. The IT services giant posted a net income of USD 2.39 billion, an i...
- Buy, Sell or Hold: Goldman Sachs remains neutral on Tata Motors; Nuvama maintains buy on HULBrokerages show selective optimism amidst market jitters. Goldman Sachs backs Shyam Metalics & Energy with a 10% upside target, anticipatin...
- No runaway rally likely; markets to trade in broad range: Sameer DalalEquity markets face near-term unevenness due to global optimism tempered by domestic uncertainties like elevated crude prices and monsoon r...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Rupee to average around 96/USD in FY27; risks from oil, dollar persist: Motilal OswalThe Indian rupee is projected to average around 96 against the US dollar in FY27. However, this outlook faces potential challenges includin...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
Load More
